Sovipostobart
Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic[1].
Product Specifications
CAS Number
2649371-19-5
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sovipostobart.html
Purity
96.528
Solubility
10 mM in DMSO
Smiles
[Sovipostobart]
Molecular Weight
(153.531 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 36, No. 4, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FBC60281-01 10 mg
Erythro-1- (4-hydroxy-3-methoxyphenyl) propane-1,2-diol
Sign In for Pricing
View Details FBC60281-02 25 mg
Erythro-1- (4-hydroxy-3-methoxyphenyl) propane-1,2-diol
Sign In for Pricing
View Details FBC60281-03 50 mg
Erythro-1- (4-hydroxy-3-methoxyphenyl) propane-1,2-diol
Sign In for Pricing
View Details 
QXA16548-01 0.5 g
2- (4-Acetylphenoxy) -N- (3,5-dimethoxyphenyl) acetamide
Sign In for Pricing
View Details QXA16548-02 5 g
2- (4-Acetylphenoxy) -N- (3,5-dimethoxyphenyl) acetamide
Sign In for Pricing
View Details 
MBS6281899-01 0.1 mL
CCDC8, CT (CCDC8, Coiled-coil domain-containing protein 8) (MaxLight 490)
Sign In for Pricing
View Details